Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,449
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,872
Class I recallsReasonable probability of serious health consequences
24,509
Class II recallsTemporary or medically reversible health consequences
2,932
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,096 recalls
Most affected stateHawaii 200 recalls mention this state

Advertisement

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,956 recalls have been announced year to date.
  • Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
  • The highest complete period was Jun 2026 (300).
  • Nov 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2

Showing 10,821–10,840 of 21,307 recalls

FDA Recall TerminatedTerminated: October 26, 2021Historical recordClass II

Brilliant Blue Ophthalmic PF INJ, 0.5mg/mL (0.05%), 1 mL SDV, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-211-31, barcode 2 69623 21131 0.

by Premier Pharmacy Labs Inc

Reason
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Published
July 3, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 26, 2021Historical recordClass II

Atropine Sulfate PF INJ, 0.8 mg/2 mL (0.4 mg/mL), 2mL Single Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-131-12, barcode 0 69623 13112 6.

by Premier Pharmacy Labs Inc

Reason
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Published
July 3, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

MethylPREDNISolone Tablets, USP 8 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-917-11

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

Pramipexole Dihydrochloride Tablets 1.5 mg 90-count bottle, Rx only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ NDC 68382-200-16

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

MethylPREDNISolone Tablets, USP 32 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-919-11

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

MethylPREDNISolone Tablets, USP 16 mg, 50 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-918-18

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

MethylPREDNISolone Tablets, USP 4 mg per tablet, 21 Tablets dosepack, Rx Only, Made in India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-916-34

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

MethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India NDC 68382-916-01

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

Pramipexole Dihydrochloride Tablets 1 mg, 90-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-199-16

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.5 mg, 90-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-198-16

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.25 mg, 1000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. NDC 68382-197-10

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

Pramipexole Dihydrochoride Tablets 0.25 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-197-16

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

Pramipexole DihydrochlorideTablets 0.125 mg, 90-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-16

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

Pramipexole Dihydrochloride Tablets 0.125 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-196-10

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

Anastrozole Tablets, USP, 1 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534. NDC 68382-209-10

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2021Historical recordClass II

ANASTROZOLE Tablets, 1 mg, Rx Only, 30-count bottle, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 NDC 68382-209-06

by Zydus Pharmaceuticals USA Inc

Reason
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 9, 2020Historical recordClass II

Cetirizine Oral Solution 1 mg/mL, Up & Up, Children's allergy relief, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. (118 mL) Bottle, Distributed by Target Corporation, Minneapolis, MN 55403, NDC 11673-178-04, UPC 359726178044.

by P & L Developments, LLC

Reason
cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 9, 2020Historical recordClass II

Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. Bottle, Distributed by C.D.M.A. Inc., Novi, MI 48376, Quality Choice, NDC 63868-430-04, UPC 635515992474.

by P & L Developments, LLC

Reason
cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 9, 2020Historical recordClass II

Cetirizine HCL Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Gluten Free, Grape Flavor, 5 mg/5mL, 4 FL. oz. Bottle, Distributed by Dolgencorp, LLC, 100 mission ridge, Goodlettsville, TN 37072, NDC 55910-878-04, UPC 359726178051.

by P & L Developments, LLC

Reason
cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Published
June 26, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 30, 2020Historical recordClass II

Anastrozole Tablets, USP, 1mg, 30-count unit dose blisters per carton, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC 60687-112-21.

by American Health Packaging

Reason
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Published
June 26, 2019
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.